Loading...
Darunavir — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Darunavir
2025-Q4
Comprehensive analysis of India’s darunavir export trade — suppliers, buyers, prices, routes, and every shipment record.
40
Shipments
$1.93M
Trade Value
7
Suppliers
29
Buyers
27
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/darunavir
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s darunavir trade — 2025-Q4
KEY TAKEAWAY
Darunavir 2025-Q4 exports total $1.9M across 27 countries, with HETERO LABS LTD commanding 75.1% market share.
TOTAL SHIPMENTS
40
2025-Q4
EXPORT VALUE
$1.9M
FOB USD
TOTAL QUANTITY
4.2M
units shipped
INDIAN SUPPLIERS
7
unique exporters
GLOBAL BUYERS
29
unique importers
DESTINATIONS
27
countries
MEDIAN UNIT PRICE
$0.699
per unit
TOP-5 SHARE
99.2%
of total USD
BRANDED SHARE
42.5%
17 shipments
DOSAGE FORMS
1
product types
6 KEY FINDINGS
1
HETERO LABS LTD is India's #1 Darunavir exporter with $1.5M (75.1% market share).→ §5, Indian Supplier Rankings
2
Darunavir reached 27 countries, with Kenya as the top destination ($574.1K).→ §4, Global Destination Map
3
Market concentration is high (HHI: 5885) — top 7 suppliers control 100.0% of exports.→ §5, Indian Supplier Rankings
4
96.6% of buyers (28 of 29) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (100.0%) across 1 dosage forms.→ §7, Price Benchmarks
6
27 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 HETERO LABS LTD leads in volume — how do 7 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian darunavir exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Darunavir report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial darunavir trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian darunavir suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Darunavir India trade report
Product scope
Darunavir
All variants merged — branded and generic formulations of darunavir
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
40
Every commercial darunavir trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $1.3M, Nov $539.6K, Dec $50.7K. Shipment counts were mixed across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$1.3M
Oct USD
19 shipments
2
$539.6K
Nov USD
-59.8% MoM
3
$50.7K
Dec USD
-90.6% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 59.8% in USD but shipment count kept steady.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $1.3M, making it the strongest month by value.
Fig 3.2 Q4 cumulative USD reached $1.9M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $803K dip in Nov, $489K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Nov’s dip was fully recovered by Dec.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $1.3M | 19 shipments |
| Nov | $540K | 18 shipments |
| Dec | $51K | 3 shipments |
| Q4 Total | $1.9M | 40 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Kenya held #1 throughout the quarter.
Fig 3.6 Top 7 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: EMCURE PHARMACEUTICALS LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import darunavir from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Kenya absorbs 29.7% of India’s 2025-Q4 darunavir trade ($574.1K). Beyond the top 10 destinations, 27 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 11 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 27 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much darunavir India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$190K
9.8% of trade
4 countries · 9 shipments
Europe
$296K
15.3% of trade
5 countries · 6 shipments
Americas
$452K
23.4% of trade
7 countries · 9 shipments
Africa
$995K
51.5% of trade
11 countries · 16 shipments
Fig 4.1 Kenya is the #1 corridor ($574K) — 27 flow arcs from India radiate across 4 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian darunavir it receives (light = low, dark = high). Orange arcs radiate from India to the top 27 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Kenya | $574K | 3 | HETERO LABS LTD | $574K | — | — | — | — |
| 2 | Zambia | $183K | 2 | HETERO LABS LTD | $183K | — | — | — | — |
| 3 | United States | $173K | 3 | MSN LABORATORIES PVT LTD | $173K | — | — | — | — |
| 4 | Poland | $160K | 2 | HETERO LABS LTD | $160K | — | — | — | — |
| 5 | Uzbekistan | $112K | 1 | HETERO LABS LTD | $112K | — | — | — | — |
| 6 | Chile | $106K | 1 | HETERO LABS LTD | $106K | — | — | — | — |
| 7 | Latvia | $105K | 1 | HETERO LABS LTD | $105K | — | — | — | — |
| 8 | Mexico | $81K | 1 | MSN LABORATORIES PVT LTD | $81K | — | — | — | — |
| 9 | Iran | $76K | 2 | EMCURE PHARMACEUTICALS LTD | $50K | S.D.PHARMACEUTICALS | $26K | — | — |
| 10 | Zimbabwe | $67K | 2 | EMCURE PHARMACEUTICALS LTD | $67K | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 9.8% of USD — but Kenya is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
29.7%
#1 country share
Kenya alone
62.2%
Top 5 share
5 of 27 countries
95.9%
Top 15 share
Long tail of 12 countries = 4.1%
HHI 1289
Destination HHI
Competitive spread
27
Countries served
Global pharma reach from India
11
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
7 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
HETERO LABS LTD ($1.5M, 75.1% share) and MSN LABORATORIES PVT LTD ($274.6K) together control 89.3% of India’s 2025-Q4 darunavir trade. The top 5 suppliers hold 99.2%. 7 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian darunavir suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 HETERO LABS LTD leads by $1.2M over MSN LABORATORIES PVT LTD — top 7 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: MYLAN LABORATORIES LTD is #6 by value but #3 by volume.
Fig 5.2 HETERO LABS LTD also leads by shipment count (21) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: MYLAN LABORATORIES LTD moves from #3 by volume to #6 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 7 darunavir suppliers split into strategic segments
KEY TAKEAWAY
2 suppliers (25%) generate 89.3% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 HETERO LABS LTD and MSN LABORATORIES PVT LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 89.3% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | HETERO LABS LTD | 1 | 17 | $1.5M |
| 2 | MSN LABORATORIES PVT LTD | 1 | 3 | $275K |
| 3 | EMCURE PHARMACEUTICALS LTD | 1 | 2 | $117K |
| 4 | M D PHARMACY | 1 | 1 | $48K |
| 5 | S.D.PHARMACEUTICALS | 1 | 1 | $26K |
| 6 | MYLAN LABORATORIES LTD | 1 | 3 | $14K |
| 7 | APPLE PHARMACEUTICALS | 1 | 1 | $1K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the darunavir manufacturing hubs
KEY TAKEAWAY
Hyderabad and Industrial Estate together account for $1.7M of India’s 2025-Q4 darunavir trade.
Fig 5.5 Hyderabad (2 exporters, $1.6M) and Industrial Estate (1 exporters, $132K) are India’s darunavir capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
99.2%
Top 5 share
5 of 7 suppliers
100.0%
Top 7 share
7 of 7 suppliers
89.3%
Top 25% share
2 suppliers = 89% USD
HHI 5885
Supplier HHI
Concentrated
7
Total suppliers
shipped Darunavir in 2025-Q4
11+ cities
Indian hubs
Hyderabad and Industrial Estate lead
§5.2 Coming next: 3 exporter deep-dive profiles
Each of the top 3 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | HETERO LABS LTD | $1.5M |
| #2 | MSN LABORATORIES PVT LTD | $275K |
| #3 | MYLAN LABORATORIES LTD | $14K |
#1
2025-Q4 USD
$1.5M
75.1% market share
SHIPMENTS
21
avg $69K/ship
COUNTRIES
17
destination markets
BUYERS
18
16 single-sourced
BRANDED
24%
of shipments
DOSAGE FORMS
1
product types
TOP 10 DESTINATIONS
Kenya is the #1 market at $574K (40% of trade), followed by Zambia at $183K. 17 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Kenya | $574K | 3 | 39.6% |
| 2 | Zambia | $183K | 2 | 12.6% |
| 3 | Poland | $160K | 2 | 11.0% |
| 4 | Uzbekistan | $112K | 1 | 7.7% |
| 5 | Chile | $106K | 1 | 7.3% |
| 6 | Latvia | $105K | 1 | 7.2% |
| 7 | Guatemala | $65K | 1 | 4.5% |
| 8 | Mozambique | $42K | 1 | 2.9% |
| 9 | Nigeria | $38K | 1 | 2.6% |
| 10 | Rwanda | $24K | 1 | 1.7% |
MONTHLY TREND
Oct peaked at $1.0M. Dec was the weakest at $0.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 16/16 LOCKED IN
16 of 16 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| NATIONAL MEDICAL STORE… | Kenya | $566K | ⚠ Locked |
| Undisclosed buyer | Poland | $132K | N/A |
| AMERICAN EMBASSY/USAID | Zambia | $131K | ⚠ Locked |
| UNDP OFFICE IN UZBEKIS… | Uzbekistan | $112K | ⚠ Locked |
| CENTRAL DE ABASTECIMIE… | Chile | $106K | ⚠ Locked |
| SIAMAGNIPHARMA | Latvia | $105K | ⚠ Locked |
| CHARITABLE ORGANIZATION | Poland | $80K | ⚠ Locked |
| SEVEN PHARMA GUATEMALA… | Guatemala | $65K | ⚠ Locked |
| MINISTERIO DA SA | Mozambique | $42K | ⚠ Locked |
| INSTITUTE OF HUMAN VIR… | Nigeria | $38K | ⚠ Locked |
#1
EXPORTER PROFILE #1 OF 3 — TRADE FLOW MAP
HETERO LABS LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P1.3 Kenya absorbs $574K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.
#2
EXPORTER PROFILE #2 OF 3
MSN LABORATORIES PVT LTD
Hyderabad · India’s #2 darunavir supplier by USD · 2025-Q4
2025-Q4 USD
$275K
14.2% market share
SHIPMENTS
5
avg $55K/ship
COUNTRIES
3
destination markets
BUYERS
3
3 single-sourced
BRANDED
40%
of shipments
DOSAGE FORMS
1
product types
TOP 3 DESTINATIONS
United States is the #1 market at $173K (63% of trade), followed by Mexico at $81K. 3 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | United States | $173K | 3 | 62.9% |
| 2 | Mexico | $81K | 1 | 29.4% |
| 3 | United Kingdom | $21K | 1 | 7.7% |
MONTHLY TREND
Oct peaked at $275K. Nov was the weakest at $0.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 3/3 LOCKED IN
3 of 3 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| NOVADOZ PHARMACEUTICAL… | United States | $173K | ⚠ Locked |
| YAKU HEALTH SA DE CV | Mexico | $81K | ⚠ Locked |
| MSN LABORATORIES EUROP… | United Kingdom | $21K | ⚠ Locked |
#2
EXPORTER PROFILE #2 OF 3 — TRADE FLOW MAP
MSN LABORATORIES PVT LTD — Supplier → Country → Importer
3 destination countries, top 5 importers per country
Fig 5.P2.3 United States absorbs $173K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 1 importers per destination.
#6
EXPORTER PROFILE #3 OF 3
MYLAN LABORATORIES LTD
Aurangabad · India’s #6 darunavir supplier by USD · 2025-Q4
2025-Q4 USD
$14K
0.7% market share
SHIPMENTS
5
avg $3K/ship
COUNTRIES
3
destination markets
BUYERS
4
3 single-sourced
BRANDED
80%
of shipments
DOSAGE FORMS
1
product types
TOP 3 DESTINATIONS
Benin is the #1 market at $10K (69% of trade), followed by Mauritania at $4K. 3 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Benin | $10K | 2 | 68.7% |
| 2 | Mauritania | $4K | 1 | 27.9% |
| 3 | Thailand | $490 | 2 | 3.4% |
MONTHLY TREND
Nov peaked at $14K. Oct was the weakest at $0.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 3/3 LOCKED IN
3 of 3 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| PROGRAMME SA | Benin | $5K | ⚠ Locked |
| Undisclosed buyer | Benin | $5K | N/A |
| SECRETARIAT EXECUTIF N… | Mauritania | $4K | ⚠ Locked |
| ATLANTA MEDICARE CO LTD | Thailand | $490 | ⚠ Locked |
#6
EXPORTER PROFILE #3 OF 3 — TRADE FLOW MAP
MYLAN LABORATORIES LTD — Supplier → Country → Importer
3 destination countries, top 5 importers per country
Fig 5.P3.3 Benin absorbs $10K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
29 importers across 27 countries — who is buying Indian darunavir and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 89.8% of total USD. 97% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian darunavir. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 NATIONAL MEDICAL STORESPLOT 261, KI is the #1 importer at $566K (29.3%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
97%
Single-source
28 buyers rely on exactly 1 Indian supplier
0%
Dual-source
0 buyers use 2 Indian suppliers
3%
Multi-source (3–4)
1 buyers diversified across 3–4
0%
Broad-source (5+)
0 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source darunavir from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Kenya 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| NATIONAL MEDICAL STORE… | HETERO LABS LTD | $566K | $0.289 | Tablet |
| UNIVERSITY OF NAIROBI | HETERO LABS LTD | $9K | $0.330 | Tablet |
Iran 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| MAH DAROUYE HAKIM UNIT | EMCURE PHARMACEUTICA… | $50K | $0.431 | Tablet |
| MAH DAROUY HAKIM | S.D.PHARMACEUTICALS | $26K | $0.642 | Tablet |
United States 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| NOVADOZ PHARMACEUTICAL… | MSN LABORATORIES PVT… | $173K | $20.443 | Tablet |
Zambia 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| AMERICAN EMBASSY/USAID | HETERO LABS LTD | $131K | $0.289 | Tablet |
Uzbekistan 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| UNDP OFFICE IN UZBEKIS… | HETERO LABS LTD | $112K | $0.659 | Tablet |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | NATIONAL MEDICAL STO… | Kenya | $566K | $566K | Premium |
| 2 | NOVADOZ PHARMACEUTIC… | United States | $173K | $58K | Premium |
| 3 | AMERICAN EMBASSY/USAID | Zambia | $131K | $131K | Premium |
| 4 | UNDP OFFICE IN UZBEK… | Uzbekistan | $112K | $112K | Premium |
| 5 | CENTRAL DE ABASTECIM… | Chile | $106K | $106K | Premium |
| 6 | SIAMAGNIPHARMA | Latvia | $105K | $105K | Premium |
| 7 | YAKU HEALTH SA DE CV | Mexico | $81K | $81K | Premium |
| 8 | CHARITABLE ORGANIZAT… | Poland | $80K | $80K | Premium |
| 9 | SEVEN PHARMA GUATEMA… | Guatemala | $65K | $65K | Premium |
| 10 | MAH DAROUYE HAKIM UNIT | Iran | $50K | $50K | Premium |
| 11 | OFFICE PHARMACEUTIQU… | Gabon | $48K | $48K | Premium |
| 12 | MINISTERIO DA SA | Mozambique | $42K | $42K | Premium |
| 13 | INSTITUTE OF HUMAN V… | Nigeria | $38K | $38K | Premium |
| 14 | NATIONAL PHARMACEUTI… | Zimbabwe | $34K | $34K | Mid |
| 15 | MAH DAROUY HAKIM | Iran | $26K | $26K | Mid |
| 16 | MSN LABORATORIES EUR… | United Kingdom | $21K | $21K | Mid |
| 17 | WORLD VISION INTERNA… | Haiti | $21K | $21K | Mid |
| 18 | UNIVERSITY OF NAIROBI | Kenya | $9K | $4K | Budget |
| 19 | MSF LOGISTIQUE | France | $7K | $7K | Budget |
| 20 | CENTRO DE INSUMOS PA… | Nicaragua | $5K | $5K | Budget |
| 21 | PROGRAMME SA | Benin | $5K | $5K | Budget |
| 22 | SECRETARIAT EXECUTIF… | Mauritania | $4K | $4K | Budget |
| 23 | SOLIDARMED | Lesotho | $4K | $4K | Budget |
| 24 | MSF SUPPLY C.V | Belgium | $3K | $3K | Budget |
| 25 | PHARMACIE CENTRALE D… | Tunisia | $1K | $1K | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 7 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 HETERO LABS LTD → NATIONAL MEDICAL STORESPLOT 261, KI is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 7 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian darunavir prices vary by supplier, country and dosage form
KEY TAKEAWAY
Darunavir prices span 162× ($0.289 → $46.70). The coefficient of variation is 1.39. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.289 | Lowest observed unit price |
| P5 | $0.289 | 5th percentile |
| P25 | $0.305 | 25th percentile (Q1) |
| Median | $0.699 | 50th percentile (Q2) |
| P75 | $23.10 | 75th percentile (Q3) |
| P95 | $46.70 | 95th percentile |
| Max | $46.70 | Highest observed unit price |
| Mean | $12.52 | Arithmetic average |
| CV | 139% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 APPLE PHARMACEUTICALS prices at $46.70/unit vs market median $0.699.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. HETERO LABS LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. MSN LABORATORIES PVT Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. S.D.PHARMACEUTICALS Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. EMCURE PHARMACEUTICALS LTD Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Nov 2025 | APPLE PHARMACEUT… | Philippines | Tablet | 7 | $326.88 | $46.70 | Specialty / small-batch |
| Nov 2025 | APPLE PHARMACEUT… | Philippines | Tablet | 7 | $326.88 | $46.70 | Specialty / small-batch |
| Nov 2025 | APPLE PHARMACEUT… | Philippines | Tablet | 5 | $233.48 | $46.70 | Specialty / small-batch |
| Nov 2025 | APPLE PHARMACEUT… | Philippines | Tablet | 5 | $233.48 | $46.70 | Specialty / small-batch |
| Nov 2025 | HETERO LABS LTD | Rwanda | Tablet | 576 | $24K | $42.15 | Specialty / small-batch |
| Oct 2025 | M D PHARMACY | Gabon | Tablet | 1K | $48K | $40.38 | Specialty / small-batch |
| Nov 2025 | HETERO LABS LTD | Saint Lucia | Tablet | 48 | $2K | $39.50 | Specialty / small-batch |
| Oct 2025 | MSN LABORATORIES… | Mexico | Tablet | 2K | $81K | $33.66 | Specialty / small-batch |
| Nov 2025 | EMCURE PHARMACEU… | Zimbabwe | Tablet | 1K | $34K | $30.52 | Specialty / small-batch |
| Nov 2025 | EMCURE PHARMACEU… | Zimbabwe | Tablet | 1K | $34K | $30.52 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Nov 2025 | HETERO LABS LTD | Zambia | Tablet | 455K | $131K | $0.289 | |
| Oct 2025 | HETERO LABS LTD | Kenya | Tablet | 2.0M | $566K | $0.289 | Bulk volume discount |
| Oct 2025 | HETERO LABS LTD | Nigeria | Tablet | 131K | $38K | $0.289 | |
| Oct 2025 | HETERO LABS LTD | Nicaragua | Tablet | 17K | $5K | $0.289 | |
| Nov 2025 | HETERO LABS LTD | Zambia | Tablet | 177K | $52K | $0.291 | |
| Nov 2025 | HETERO LABS LTD | Poland | Tablet | 275K | $80K | $0.291 | |
| Nov 2025 | HETERO LABS LTD | Poland | Tablet | 275K | $80K | $0.291 | |
| Nov 2025 | HETERO LABS LTD | Haiti | Tablet | 72K | $21K | $0.291 | |
| Oct 2025 | HETERO LABS LTD | Tunisia | Tablet | 4K | $1K | $0.292 | |
| Oct 2025 | HETERO LABS LTD | Belgium | Tablet | 9K | $3K | $0.292 |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship darunavir, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Darunavir leaves India through 6+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), HYDERABAD AIR, MUMBAI AIR (SAHAR)) handle 98.1% of total USD. AIR moves 85% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $650K — top 6 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 Entebbe is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
AIR dominates at 85% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$1.2M
64.4% of USD · 85.0% of ships
SEA
$650K
33.6% of USD · 10.0% of ships
ICD
$37K
1.9% of USD · 5.0% of ships
Fig 8.3 The dominant corridor is NHAVA SHEVA SEA (JNPT) → Sea → Africa ($645K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Philippines is the most concentrated destination (HHI 10000, 1 suppliers). Iran is the most competitive (HHI 5523).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Philippines (HHI 10,000) is the most concentrated — Iran (HHI 5,523) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| NATIONAL MEDICAL STO… | Kenya | HETERO LABS LTD | $566K | 1 | CRITICAL |
| NOVADOZ PHARMACEUTIC… | United States | MSN LABORATORIES… | $173K | 3 | HIGH |
| AMERICAN EMBASSY/USAID | Zambia | HETERO LABS LTD | $131K | 1 | HIGH |
| UNDP OFFICE IN UZBEK… | Uzbekistan | HETERO LABS LTD | $112K | 1 | HIGH |
| CENTRAL DE ABASTECIM… | Chile | HETERO LABS LTD | $106K | 1 | HIGH |
| SIAMAGNIPHARMA | Latvia | HETERO LABS LTD | $105K | 1 | HIGH |
| YAKU HEALTH SA DE CV | Mexico | MSN LABORATORIES… | $81K | 1 | MEDIUM |
| CHARITABLE ORGANIZAT… | Poland | HETERO LABS LTD | $80K | 1 | MEDIUM |
Conclusion: 27 buyers depend on exactly one Indian supplier, representing $1.7M in trade. 1 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Kenya | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Zambia | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| United States | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Poland | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Uzbekistan | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Chile | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Latvia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Mexico | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Iran | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Zimbabwe | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Guatemala | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Gabon | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Mozambique | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Nigeria | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Rwanda | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 15 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Kenya | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Philippines lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Kenya (1 suppliers) | This Q | HIGH |
| A6 | Enter Zambia (1 suppliers) | This Q | MED |
| A8 | Build Zambia distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for Kenya tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Kenya | Africa | 1 | $574K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Zambia | Africa | 1 | $183K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | United States | Other | 1 | $173K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Poland | Other | 1 | $160K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Uzbekistan | Asia | 1 | $112K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Chile | Other | 1 | $106K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Latvia | Other | 1 | $105K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Mexico | Other | 1 | $81K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Iran | Other | 2 | $76K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Zimbabwe | Africa | 1 | $67K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Guatemala | Other | 1 | $65K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Gabon | Africa | 1 | $48K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Mozambique | Africa | 1 | $42K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Nigeria | Africa | 1 | $38K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Rwanda | Africa | 1 | $24K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 40 2025-Q4 Darunavir shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/darunavir
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 40 2025-Q4 darunavir shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian darunavir shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
40
across all regions
TOTAL USD
$1.93M
2025-Q4 FOB value
UNITS
4.2M
tablets, capsules, etc.
SUPPLIERS
7
Indian exporters
BUYERS
29
global importers
COUNTRIES
27
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $995K (51.5%), spanning 11 countries.
7 Indian suppliers shipped to 29 buyers across 27 countries — average shipment value $48K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
11 countries · 16 shipments · $995K · 4 Indian suppliers · 13 buyers
SHIPMENTS
16
USD
$995K
COUNTRIES
11
SUPPLIERS
4
BUYERS
13
HHI
7,639
concentrated
Top 11 destination countries in Africa
1
Kenya (57.7%)
$574K
2
Zambia (18.4%)
$183K
3
Zimbabwe (6.7%)
$67K
4
Gabon (4.9%)
$48K
5
Mozambique (4.2%)
$42K
6
Nigeria (3.8%)
$38K
7
Rwanda (2.4%)
$24K
8
Benin (1.0%)
$10K
9
Mauritania (0.4%)
$4K
10
Lesotho (0.4%)
$4K
11
Tunisia (0.1%)
$1K
Top 4 Indian suppliers into Africa
1
HETERO LABS LTD
$866K
2
EMCURE PHARMACEUTICALS LTD
$67K
3
M D PHARMACY
$48K
4
MYLAN LABORATORIES LTD
$14K
Top 11 Africa importers
1
NATIONAL MEDICAL STORESPLOT 261, KI · Kenya
$566K
2
AMERICAN EMBASSY/USAID · Zambia
$131K
3
OFFICE PHARMACEUTIQUE NATIONAL (OPN · Gabon
$48K
4
MINISTERIO DA SA · Mozambique
$42K
5
INSTITUTE OF HUMAN VIROLOGY NIGERIA · Nigeria
$38K
6
NATIONAL PHARMACEUTICAL COMPANY (NA · Zimbabwe
$34K
7
UNIVERSITY OF NAIROBI · Kenya
$9K
8
PROGRAMME SA · Benin
$5K
9
SECRETARIAT EXECUTIF NATIONAL DE LU · Mauritania
$4K
10
SOLIDARMED · Lesotho
$4K
11
PHARMACIE CENTRALE DE TUNISIE · Tunisia
$1K
Top 1 dosage forms
1
Tablet
$995K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 7 | $665K | $95K |
| Nov | 9 | $330K | $37K |
| Dec | 0 | $0.0000 | — |
Shipment register · 16 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — HETERO LABS LTD · 10 shipments · $866K | |||||||||||
| 1 | Oct 2025 | PHARMACIE CENTRALE DE TUNISIE | Tunisia | Tablet | 4.3K | NOS | $0.292 | $1K | HYDERABAD AIR | TUNIS | AIR |
| 2 | Oct 2025 | UNIVERSITY OF NAIROBI | Kenya | Tablet | 14.2K | NOS | $0.331 | $5K | HYDERABAD AIR | NAIROBI | AIR |
| 3 | Oct 2025 | UNIVERSITY OF NAIROBI | Kenya | Tablet | 11.7K | NOS | $0.329 | $4K | HYDERABAD AIR | NAIROBI | AIR |
| 4 | Oct 2025 | SOLIDARMED | Lesotho | Tablet | 8.6K | NOS | $0.415 | $4K | HYDERABAD AIR | MASERU | AIR |
| 5 | Oct 2025 | NATIONAL MEDICAL STORESPLOT 261, KI | Kenya | Tablet | 2.0M | NOS | $0.289 | $566K | NHAVA SHEVA SEA (JNPT) | Entebbe | SEA |
| 6 | Oct 2025 | INSTITUTE OF HUMAN VIROLOGY NIGERIA | Nigeria | Tablet | 131.0K | NOS | $0.289 | $38K | NHAVA SHEVA SEA (JNPT) | Apapa | SEA |
| 7 | Nov 2025 | UNLISTED BUYER | Rwanda | Tablet | 576 | NOS | $42.15 | $24K | MUMBAI AIR (SAHAR) | KIGALI - | AIR |
| 8 | Nov 2025 | AMERICAN EMBASSY/USAID | Zambia | Tablet | 455.0K | NOS | $0.289 | $131K | MUMBAI AIR (SAHAR) | LUSAKA | AIR |
| 9 | Nov 2025 | UNKNOWN BUYER | Zambia | Tablet | 177.1K | NOS | $0.291 | $52K | MUMBAI AIR (SAHAR) | LUSAKA | AIR |
| 10 | Nov 2025 | MINISTERIO DA SA | Mozambique | Tablet | 63.4K | NOS | $0.657 | $42K | NHAVA SHEVA SEA (JNPT) | Maputo | SEA |
| SUPPLIER #2 — EMCURE PHARMACEUTICALS LTD · 2 shipments · $67K | |||||||||||
| 11 | Nov 2025 | NATIONAL PHARMACEUTICAL COMPANY (NA | Zimbabwe | Tablet | 1.1K | NOS | $30.52 | $34K | DELHI AIR | HARARE | AIR |
| 12 | Nov 2025 | UNKNOWN BUYER | Zimbabwe | Tablet | 1.1K | NOS | $30.52 | $34K | DELHI AIR | HARARE | AIR |
| SUPPLIER #3 — M D PHARMACY · 1 shipments · $48K | |||||||||||
| 13 | Oct 2025 | OFFICE PHARMACEUTIQUE NATIONAL (OPN | Gabon | Tablet | 1.2K | NOS | $40.38 | $48K | AHMEDABAD AIR | LIBREVILLE | AIR |
| SUPPLIER #4 — MYLAN LABORATORIES LTD · 3 shipments · $14K | |||||||||||
| 14 | Nov 2025 | PROGRAMME SA | Benin | Tablet | 7.1K | NOS | $0.699 | $5K | MUMBAI AIR (SAHAR) | COTONOU | AIR |
| 15 | Nov 2025 | UNKNOWN BUYER | Benin | Tablet | 7.1K | NOS | $0.699 | $5K | MUMBAI AIR (SAHAR) | COTONOU | AIR |
| 16 | Nov 2025 | SECRETARIAT EXECUTIF NATIONAL DE LU | Mauritania | Tablet | 5.8K | NOS | $0.699 | $4K | MUMBAI AIR (SAHAR) | NOUAKCHOTT | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
4 countries · 9 shipments · $190K · 5 Indian suppliers · 6 buyers
SHIPMENTS
9
USD
$190K
COUNTRIES
4
SUPPLIERS
5
BUYERS
6
HHI
4,380
concentrated
Top 4 destination countries in Asia
1
Uzbekistan (59.1%)
$112K
2
Iran (40.0%)
$76K
3
Philippines (0.6%)
$1K
4
Thailand (0.3%)
$489.91
Top 5 Indian suppliers into Asia
1
HETERO LABS LTD
$112K
2
EMCURE PHARMACEUTICALS LTD
$50K
3
S.D.PHARMACEUTICALS
$26K
4
APPLE PHARMACEUTICALS
$1K
5
MYLAN LABORATORIES LTD
$489.91
Top 5 Asia importers
1
UNDP OFFICE IN UZBEKISTAN · Uzbekistan
$112K
2
MAH DAROUYE HAKIM UNIT · Iran
$50K
3
MAH DAROUY HAKIM · Iran
$26K
4
SHIP CLINIC INC · Philippines
$560.36
5
ATLANTA MEDICARE CO LTD · Thailand
$489.91
Top 1 dosage forms
1
Tablet
$190K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $112K | $112K |
| Nov | 5 | $27K | $5K |
| Dec | 3 | $51K | $17K |
Shipment register · 9 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — HETERO LABS LTD · 1 shipments · $112K | |||||||||||
| 1 | Oct 2025 | UNDP OFFICE IN UZBEKISTAN | Uzbekistan | Tablet | 169.9K | NOS | $0.659 | $112K | HYDERABAD AIR | TASHKENT | AIR |
| SUPPLIER #2 — EMCURE PHARMACEUTICALS LTD · 1 shipments · $50K | |||||||||||
| 2 | Dec 2025 | MAH DAROUYE HAKIM UNIT | Iran | Tablet | 116.6K | NOS | $0.431 | $50K | DELHI AIR | TEHRAN | AIR |
| SUPPLIER #3 — S.D.PHARMACEUTICALS · 1 shipments · $26K | |||||||||||
| 3 | Nov 2025 | MAH DAROUY HAKIM | Iran | Tablet | 40.0K | NOS | $0.642 | $26K | DELHI AIR | TEHRAN | AIR |
| SUPPLIER #4 — APPLE PHARMACEUTICALS · 4 shipments · $1K | |||||||||||
| 4 | Nov 2025 | SHIP CLINIC INC | Philippines | Tablet | 5 | NOS | $46.70 | $233.48 | MUMBAI AIR (SAHAR) | MANILA | AIR |
| 5 | Nov 2025 | SHIP CLINIC INC | Philippines | Tablet | 7 | NOS | $46.70 | $326.88 | MUMBAI AIR (SAHAR) | MANILA | AIR |
| 6 | Nov 2025 | UNKNOWN BUYER | Philippines | Tablet | 5 | NOS | $46.70 | $233.48 | MUMBAI AIR (SAHAR) | MANILA | AIR |
| 7 | Nov 2025 | UNKNOWN BUYER | Philippines | Tablet | 7 | NOS | $46.70 | $326.88 | MUMBAI AIR (SAHAR) | MANILA | AIR |
| SUPPLIER #5 — MYLAN LABORATORIES LTD · 2 shipments · $489.91 | |||||||||||
| 8 | Dec 2025 | ATLANTA MEDICARE CO LTD | Thailand | Tablet | 600 | NOS | $0.786 | $471.70 | MUMBAI AIR (SAHAR) | BANGKOK | AIR |
| 9 | Dec 2025 | ATLANTA MEDICARE CO LTD | Thailand | Tablet | 1 | NOS | $18.22 | $18.22 | MUMBAI AIR (SAHAR) | BANGKOK | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
5 countries · 6 shipments · $296K · 2 Indian suppliers · 6 buyers
SHIPMENTS
6
USD
$296K
COUNTRIES
5
SUPPLIERS
2
BUYERS
6
HHI
8,675
concentrated
Top 5 destination countries in Europe
1
Poland (54.2%)
$160K
2
Latvia (35.4%)
$105K
3
United Kingdom (7.1%)
$21K
4
France (2.4%)
$7K
5
Belgium (0.9%)
$3K
Top 2 Indian suppliers into Europe
1
HETERO LABS LTD
$275K
2
MSN LABORATORIES PVT LTD
$21K
Top 5 Europe importers
1
SIAMAGNIPHARMA · Latvia
$105K
2
CHARITABLE ORGANIZATION · Poland
$80K
3
MSN LABORATORIES EUROPE LTD · United Kingdom
$21K
4
MSF LOGISTIQUE · France
$7K
5
MSF SUPPLY C.V · Belgium
$3K
Top 1 dosage forms
1
Tablet
$296K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 4 | $136K | $34K |
| Nov | 2 | $160K | $80K |
| Dec | 0 | $0.0000 | — |
Shipment register · 6 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — HETERO LABS LTD · 5 shipments · $275K | |||||||||||
| 1 | Oct 2025 | SIAMAGNIPHARMA | Latvia | Tablet | 90.2K | NOS | $1.16 | $105K | HYDERABAD AIR | RIGA | AIR |
| 2 | Oct 2025 | MSF SUPPLY C.V | Belgium | Tablet | 8.6K | NOS | $0.292 | $3K | HYDERABAD AIR | BRUSSELS | AIR |
| 3 | Oct 2025 | MSF LOGISTIQUE | France | Tablet | 23.0K | NOS | $0.309 | $7K | HYDERABAD AIR | BORDEAUX | AIR |
| 4 | Nov 2025 | CHARITABLE ORGANIZATION | Poland | Tablet | 275.0K | NOS | $0.291 | $80K | MUMBAI AIR (SAHAR) | WARSAW | AIR |
| 5 | Nov 2025 | UNKNOWN BUYER | Poland | Tablet | 275.0K | NOS | $0.291 | $80K | MUMBAI AIR (SAHAR) | WARSAW | AIR |
| SUPPLIER #2 — MSN LABORATORIES PVT LTD · 1 shipments · $21K | |||||||||||
| 6 | Oct 2025 | MSN LABORATORIES EUROPE LTD | United Kingdom | Tablet | 3.8K | NOS | $5.58 | $21K | HYDERABAD ICD | SOUTHAMPTON | ICD |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
7 countries · 9 shipments · $452K · 2 Indian suppliers · 7 buyers
SHIPMENTS
9
USD
$452K
COUNTRIES
7
SUPPLIERS
2
BUYERS
7
HHI
5,074
concentrated
Top 7 destination countries in Americas
1
United States (38.2%)
$173K
2
Chile (23.4%)
$106K
3
Mexico (17.9%)
$81K
4
Guatemala (14.4%)
$65K
5
Haiti (4.6%)
$21K
6
Nicaragua (1.1%)
$5K
7
Saint Lucia (0.4%)
$2K
Top 2 Indian suppliers into Americas
1
MSN LABORATORIES PVT LTD
$253K
2
HETERO LABS LTD
$199K
Top 6 Americas importers
1
NOVADOZ PHARMACEUTICALS LLC · United States
$173K
2
CENTRAL DE ABASTECIMIENTO · Chile
$106K
3
YAKU HEALTH SA DE CV · Mexico
$81K
4
SEVEN PHARMA GUATEMALA S.A · Guatemala
$65K
5
WORLD VISION INTERNATIONAL-HAITI · Haiti
$21K
6
CENTRO DE INSUMOS PARA LA SA · Nicaragua
$5K
Top 1 dosage forms
1
Tablet
$452K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 7 | $429K | $61K |
| Nov | 2 | $23K | $11K |
| Dec | 0 | $0.0000 | — |
Shipment register · 9 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — MSN LABORATORIES PVT LTD · 4 shipments · $253K | |||||||||||
| 1 | Oct 2025 | YAKU HEALTH SA DE CV | Mexico | Tablet | 2.4K | NOS | $33.66 | $81K | HYDERABAD AIR | MEXICO CITY | AIR |
| 2 | Oct 2025 | NOVADOZ PHARMACEUTICALS LLC | United States | Tablet | 3.8K | NOS | $20.42 | $78K | HYDERABAD AIR | CHICAGO O'HARE INT'L | AIR |
| 3 | Oct 2025 | NOVADOZ PHARMACEUTICALS LLC | United States | Tablet | 3.8K | NOS | $20.42 | $78K | HYDERABAD AIR | CHICAGO, IL | AIR |
| 4 | Oct 2025 | NOVADOZ PHARMACEUTICALS LLC | United States | Tablet | 768 | NOS | $20.63 | $16K | HYDERABAD ICD | NORFOLK | ICD |
| SUPPLIER #2 — HETERO LABS LTD · 5 shipments · $199K | |||||||||||
| 5 | Oct 2025 | SEVEN PHARMA GUATEMALA S.A | Guatemala | Tablet | 90.0K | TBS | $0.722 | $65K | HYDERABAD AIR | GUATEMALA CITY | AIR |
| 6 | Oct 2025 | CENTRO DE INSUMOS PARA LA SA | Nicaragua | Tablet | 17.3K | NOS | $0.289 | $5K | NHAVA SHEVA SEA (JNPT) | Corinto | SEA |
| 7 | Oct 2025 | CENTRAL DE ABASTECIMIENTO | Chile | Tablet | 158.4K | NOS | $0.668 | $106K | HYDERABAD AIR | SANTIAGO DE CHILE - | AIR |
| 8 | Nov 2025 | UNLISTED BUYER | Saint Lucia | Tablet | 48 | NOS | $39.50 | $2K | MUMBAI AIR (SAHAR) | ST LUCIA | AIR |
| 9 | Nov 2025 | WORLD VISION INTERNATIONAL-HAITI | Haiti | Tablet | 72.0K | NOS | $0.291 | $21K | MUMBAI AIR (SAHAR) | PORT AU PRINCE | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 7 Indian darunavir exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped darunavir in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | HETERO LABS LTD | HYDERABAD | 21 | $1.45M | Tablet | Africa, Europe |
| 2 | MSN LABORATORIES PVT LTD | HYDERABAD | 5 | $275K | Tablet | Americas, Europe |
| 3 | EMCURE PHARMACEUTICALS LTD | JAMMU JK | 3 | $117K | Tablet | Africa, Asia |
| 4 | M D PHARMACY | BHOPAL | 1 | $48K | Tablet | Africa |
| 5 | S.D.PHARMACEUTICALS | CENTER VIKAS PURI NEW DELHI | 1 | $26K | Tablet | Asia |
| 6 | MYLAN LABORATORIES LTD | AURANGABAD | 5 | $14K | Tablet | Africa, Asia |
| 7 | APPLE PHARMACEUTICALS | MUMBAI | 4 | $1K | Tablet | Asia |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 27 global darunavir importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian darunavir in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | NATIONAL MEDICAL STORESPLOT 261, KI | Kenya | 1 | $566K | HETERO LABS LTD | Tablet |
| 2 | NOVADOZ PHARMACEUTICALS LLC | United States | 3 | $173K | MSN LABORATORIES PVT… | Tablet |
| 3 | AMERICAN EMBASSY/USAID | Zambia | 1 | $131K | HETERO LABS LTD | Tablet |
| 4 | UNDP OFFICE IN UZBEKISTAN | Uzbekistan | 1 | $112K | HETERO LABS LTD | Tablet |
| 5 | CENTRAL DE ABASTECIMIENTO | Chile | 1 | $106K | HETERO LABS LTD | Tablet |
| 6 | SIAMAGNIPHARMA | Latvia | 1 | $105K | HETERO LABS LTD | Tablet |
| 7 | YAKU HEALTH SA DE CV | Mexico | 1 | $81K | MSN LABORATORIES PVT… | Tablet |
| 8 | CHARITABLE ORGANIZATION | Poland | 1 | $80K | HETERO LABS LTD | Tablet |
| 9 | SEVEN PHARMA GUATEMALA S.A | Guatemala | 1 | $65K | HETERO LABS LTD | Tablet |
| 10 | MAH DAROUYE HAKIM UNIT | Iran | 1 | $50K | EMCURE PHARMACEUTICA… | Tablet |
| 11 | OFFICE PHARMACEUTIQUE NATIONAL (OPN | Gabon | 1 | $48K | M D PHARMACY | Tablet |
| 12 | MINISTERIO DA SA | Mozambique | 1 | $42K | HETERO LABS LTD | Tablet |
| 13 | INSTITUTE OF HUMAN VIROLOGY NIGERIA | Nigeria | 1 | $38K | HETERO LABS LTD | Tablet |
| 14 | NATIONAL PHARMACEUTICAL COMPANY (NA | Zimbabwe | 1 | $34K | EMCURE PHARMACEUTICA… | Tablet |
| 15 | MAH DAROUY HAKIM | Iran | 1 | $26K | S.D.PHARMACEUTICALS | Tablet |
| 16 | MSN LABORATORIES EUROPE LTD | United Kingdom | 1 | $21K | MSN LABORATORIES PVT… | Tablet |
| 17 | WORLD VISION INTERNATIONAL-HAITI | Haiti | 1 | $21K | HETERO LABS LTD | Tablet |
| 18 | UNIVERSITY OF NAIROBI | Kenya | 2 | $9K | HETERO LABS LTD | Tablet |
| 19 | MSF LOGISTIQUE | France | 1 | $7K | HETERO LABS LTD | Tablet |
| 20 | CENTRO DE INSUMOS PARA LA SA | Nicaragua | 1 | $5K | HETERO LABS LTD | Tablet |
| 21 | PROGRAMME SA | Benin | 1 | $5K | MYLAN LABORATORIES LTD | Tablet |
| 22 | SECRETARIAT EXECUTIF NATIONAL DE LU | Mauritania | 1 | $4K | MYLAN LABORATORIES LTD | Tablet |
| 23 | SOLIDARMED | Lesotho | 1 | $4K | HETERO LABS LTD | Tablet |
| 24 | MSF SUPPLY C.V | Belgium | 1 | $3K | HETERO LABS LTD | Tablet |
| 25 | PHARMACIE CENTRALE DE TUNISIE | Tunisia | 1 | $1K | HETERO LABS LTD | Tablet |
| 26 | SHIP CLINIC INC | Philippines | 2 | $560.36 | APPLE PHARMACEUTICALS | Tablet |
| 27 | ATLANTA MEDICARE CO LTD | Thailand | 2 | $489.91 | MYLAN LABORATORIES LTD | Tablet |
This report covers 40 2025-Q4 Darunavir shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/darunavir
Talk to our trade analyst
Need a custom darunavir report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/darunavir
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Darunavir product page
Live data, supplier directory, price trends, and trade route analysis